BRILINTA® - AstraZeneca US
WEBThis web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.
Brilinta approved in the US to reduce the risk of stroke ... - AstraZeneca
WEBNov 6, 2020 · AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5) or high-risk transient ischaemic attack (TIA).
BRILINTA Cost and Patient Assistance Programs | BRILINTA® …
WEBLearn how much BRILINTA® (ticagrelor) might cost and about assistance programs from AstraZeneca that can help you if you can’t afford your medication. What can I expect to pay for BRILINTA? The list price for BRLINTA is $425.21 * for a 30-day supply.
Brilinta approved in the US to reduce the risk of a first ... - AstraZeneca
WEBJun 1, 2020 · AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease (CAD), the most common type of heart disease.
BRILINTA - Treatment | ACS | Acute Ischemic Stroke | CAD
WEBBRILINTA is a prescription medicine for adults used to: decrease your risk of death, heart attack, and stroke in people with a blockage of blood flow to the heart (acute coronary syndrome or ACS) or a history of a heart attack.
Brilinta Uses, Dosage & Side Effects - Drugs.com
WEBDec 21, 2022 · Brilinta prevents platelets in your blood from sticking together to form an unwanted blood clot that could block an artery. Brilinta is used to lower your risk of heart attack, stroke, or death due to a blocked artery or a prior heart attack.
AstraZeneca enrols first patient in new Brilinta (ticagrelor) stroke trial
WEBJan 23, 2018 · Brilinta, co-administered with aspirin, also known as acetylsalicylic acid (ASA), is indicated for the prevention of atherothrombotic events in adult patients with ACS, or for patients with a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic event.
Acute Ischemic Stroke | BRILINTA® (ticagrelor) tablets
WEBBRILINTA is used to lower your chance of having, or dying from, a heart attack or stroke, but BRILINTA (and similar drugs) can cause bleeding that can be serious and sometimes lead to death. Instances of serious bleeding, such as internal bleeding, may require blood transfusions or surgery.
BRILINTA Approved in the US to Reduce the Risk of Stroke in …
WEBNov 6, 2020 · INDICATIONS. BRILINTA is indicated to reduce the risk of cardiovascular death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial...
WEBBRILINTA®. ticagrelor. Tablet, 60 and 90 mg, Oral Use. Platelet Aggregation Inhibitor. AstraZeneca Canada Inc. 1004 Middlegate Road Mississauga, Ontario. L4Y 1M4 www.astrazeneca.ca. Submission Control Number: 276332 Date of Initial Authorization: MAY 30, 2011. Date of Revision: NOV 14, 2023.
Skip to content